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Background: NADH dehydrogenase subunit-2 237 leucine/methionine (ND2-237 Leu/Met) polymorphism is
associated with longevity in Japanese. A previous study has shown that ND2-237 Leu/Met polymorphism modulates
the effects of green tea consumption on risk of hypertension. For men with ND2-237Leu, habitual green tea
consumption may reduce the risk of hypertension. Moreover, there is a combined effect of ND2-237 Leu/Met
polymorphism and alcohol consumption on risk of mildly decreased estimated glomerular filtration rate (eGFR)
(<90 ml/min/1.73 m2). Several beneficial effects of green tea on the kidney have been reported. The objective of
this study was to investigate whether ND2-237 Leu/Met polymorphism modifies the effects of green tea
consumption on risk of mildly decreased eGFR in male Japanese health check-up examinees.
Results: For ND2-237Leu genotypic men, after adjustment for confounding factors, green tea consumption may
increase the risk of mildly decreased eGFR (P for trend = 0.016). The adjusted odds ratio (OR) for mildly decreased
eGFR was significantly higher in subjects with ND2-237Leu who consume ≥6 cups of green tea per day than those
who consume ≤1 cup of green tea per day (adjusted OR = 5.647, 95% confidence interval: 1.528-20.88, P = 0.009).
On the other hand, for ND2-237Met genotypic men, green tea consumption does not appear to determine the risk
of mildly decreased eGFR.
Conclusion: The present results suggest that ND2-237 Leu/Met polymorphism unexpectedly modifies the effects of
green tea consumption on eGFR and the risk of mildly decreased eGFR in male Japanese subjects.
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Green tea consumption contributes to a reduction in the
risk of cardiovascular disease and some types of malig-
nancy, as well as to the promotion of oral health and
other physiological functions [1]. Several beneficial ef-
fects of green tea on the kidney have also been reported
[2-11]. In experimental animal models, green tea extract
(GTE) exhibits protective effects on renal disorder [2-9].
In vitro experiments have shown that GTE exerts pro-
tective effects against oxidative injury in human mesan-
gial cells [10]. A case–control study reported that green
tea consumption is associated with a decreased risk of
renal cell carcinoma in the Chinese population [11].
Mitochondrial DNA cytosine/adenine polymorphism,
which is also recognized as NADH dehydrogenase sub-
unit-2 237 leucine/methionine (ND2-237 Leu/Met) poly-
morphism, is associated with longevity in Japanese [12].
The frequency of the ND2-237Met genotype is signifi-
cantly higher in Japanese centenarians than in the gen-
eral population. On the other hand, Japanese individuals
with ND2-237Leu are more susceptible to adult-onset
diseases, such as hypertension [13], diabetes [14], myo-
cardial infarction [15,16] and cerebrovascular disorders
[17], than those with ND2-237Met. Our previous cross-
sectional study showed that ND2-237 Leu/Met polymor-
phism modulates the effects of green tea consumptionTable 1 Clinical characteristics of study subjects by ND2-237
Age (y)
Body mass index (kg/m2)
Systolic blood pressure (mmHg)
Diastolic blood pressure (mmHg)
Serum total cholesterol (mg/dl)
Serum HDL cholesterol (mg/dl)
Serum triglyceride (mg/dl)
Fasting plasma glucose (mg/dl)
Serum uric acid (mg/dl)
Blood urea nitrogen (mg/dl)
Serum creatinine (mg/dl)
eGFR (ml/min/1.73 m2)
Renal function (eGFR≥ 90/ 90 > eGFR≥ 60/ eGFR < 60) (%)
Antihypertensive medications (%)
Green tea consumption (≤1 cups per day/2-3 cups per day/4-5 cups per day/≥
Alcohol consumption (daily/occasionally/non-) (%)
Smoking status (non- or ex-/ 1–20 cigarettes per day/ >20 cigarettes per day
Coffee consumption (≤1 cup per day/2-3 cups per day/≥4 cups per day) (%)
HDL: high-density lipoprotein. eGFR: estimated glomerular filtration rate. Age, body ma
levels, serum HDL cholesterol levels, serum triglyceride levels, fasting plasma glucose le
and eGFR are given as means ± S.D. For renal function, antihypertensive medications, g
consumption, P values were calculated by chi-squared test. All P values depict significaon the risk of hypertension [18]. For men with ND2-
237Leu, green tea consumption may reduce the risk of
hypertension. We also reported the joint effects of this
polymorphism and alcohol consumption on estimated
glomerular filtration rate (eGFR) [19]. For ND2-237Met
genotypic men, alcohol consumption may ameliorate
eGFR. Both reports [18,19] demonstrated the positive ef-
fects of green tea consumption on renal function, at least
in either genotype of ND2-237 Leu/Met polymorphism.
The aim of this study was to investigate whether
ND2-237 Leu/Met polymorphism modulates the ef-
fects of green tea consumption on kidney function in
male Japanese health check-up examinees.
Results
No significant differences in clinical characteristics were
observed between the ND2-237Leu and ND2-237Met
genotypes (Table 1). However, although differences did
not reach significance, serum creatinine levels were
higher and eGFR was lower in men with ND2-237Leu
than in those with ND2-237Met (P = 0.090 and P = 0.066,
respectively). Chi-squared test showed no significant dif-
ferences in green tea consumption between the ND2-237
Leu/Met genotypes.
For both ND2-237Leu and ND2-237Met genotypic men,
the frequency of green tea consumption was negativelyLeu/Met genotype
ND2-237Leu ND2-237Met P value
N = 239 N = 155
54.3 ± 7.8 53.2 ± 7.8 0.171
23.3 ± 2.8 23.5 ± 2.6 0.461
125.8 ± 15.9 125.7 ± 14.1 0.940
74.0 ± 10.7 73.8 ± 9.1 0.823
203.5 ± 34.3 202.1 ± 31.8 0.672
54.6 ± 13.6 56.3 ± 16.2 0.269
136.7 ± 91.1 139.5 ± 90.8 0.766
97.2 ± 9.4 97.6 ± 9.7 0.672
5.98 ± 1.21 5.93 ± 1.21 0.673
15.8 ± 3.7 15.2 ± 3.4 0.143
0.817 ± 0.117 0.797 ± 0.111 0.090
79.1 ± 13.1 81.5 ± 12.4 0.066
17.6/77.8/4.6 25.2/72.2/2.6 0.133
18.8 12.9 0.122
6 cups per day) (%) 26.8/30.1/21.8/21.3 27.7/33.6/20.0/18.7 0.840
46.4/35.2/18.4 47.7/38.7/13.6 0.426
) (%) 59.4/29.7/10.9 59.4/25.8/14.8 0.429
61.1/29.7/9.2 55.5/32.9/11.6 0.510
ss index, systolic blood pressure, diastolic blood pressure, serum total cholesterol
vels, serum uric acid levels, blood urea nitrogen levels, serum creatinine levels
reen tea consumption, alcohol consumption, smoking status and coffee
nce of differences between ND2-237Leu and ND2-237Met.
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and P for trend = 0.049, respectively) (Table 2). However,
after adjustment for age and BMI, or for age, BMI, alcohol
consumption, habitual smoking, coffee consumption and
use of antihypertensive medication, significant associa-
tions of green tea consumption with eGFR disappeared in
both genotypes.
For subjects with ND2-237Leu, when compared with
those who consume ≤1 cup of green tea per day, the
odds ratios (ORs) for mildly decreased eGFR were 1.957,
2.152 and 4.598 for consumption of 2–3, 4–5 and ≥6
cups of green tea per day, respectively (P for trend =
0.007) (Table 3). After controlling for age, BMI, alcohol
consumption, habitual smoking, coffee consumption and
use of antihypertensive medication, the positive asso-
ciations between increasing frequency of green tea
consumption and the risk of mildly decreased eGFR
remained significant (P for trend = 0.016). The crude OR
for mildly decreased eGFR was significantly higher in
subjects with ND2-237Leu who consume ≥6 cups of
green tea per day than in those who consume ≤1 cup of
green tea per day (OR = 4.598, 95% confidence interval
(CI): 1.445-14.63, P = 0.010). After the aforementioned
variables were adjusted, a significant OR remained
(adjusted OR = 5.647, 95% CI: 1.528-20.88, P = 0.009).
On the other hand, the association between ND2-
237Met genotype and the risk of mildly decreased eGFR
does not appear to depend on green tea consumption.
However, after controlling the aforementioned variables,
the OR for mildly decreased eGFR was significantly
higher in subjects with ND2-237Met who consume 2–3
cups of green tea per day than in those who consume ≤1
cup of green tea per day (OR = 2.943, 95% CI: 1.023-8.461,
P = 0.045).Table 2 Estimated glomerular filtration rate by green tea con
Genotype and green tea consumption eGFR (ml/min/1.73 m2)
ND2-237Leu (N = 239)
≤1 cup per day (N = 64) 81.7 ± 1.6
2–3 cups per day (N = 72) 80.2 ± 1.5
4–5 cups per day (N = 52) 75.6 ± 1.8
≥6 cups per day (N = 51) 77.8 ± 1.8
P for trend = 0.031
ND2-237Met (N = 155)
≤1 cup per day (N = 43) 84.9 ± 1.9
2–3 cups per day (N = 52) 80.3 ± 1.7
4–5 cups per day (N = 31) 82.2 ± 2.2
≥6 cups per day (N = 29) 78.1 ± 2.3
P for trend = 0.049
eGFR: estimated glomerular filtration rate. †eGFR is given as least-square mean ± S.E
adjusted for age, body mass index, habitual smoking, alcohol consumption, coffee
multiple comparisons was used.Discussion
In the present study, we observed that ND2-237 Leu/Met
polymorphism apparently modifies the effects of green tea
consumption on the risk of mildly decreased eGFR in
Japanese male subjects. Considering that green tea con-
sumption contributes to human health [1], more con-
sumption of green tea is expected to exert a desirable
effect on kidney function in either genotype. However,
unexpectedly, for men with ND2-237Leu, green tea
drinking may increase the risk of mildly decreased eGFR.
On the other hand, for those with ND2-237Met, green tea
consumption does not appear to influence the risk of
mildly decreased eGFR.
Certainly, in experimental animal models, there have
been numerous investigations into the protective effects
of GTE on renal damage [2-9]. GTE improves eGFR in
streptozotocin-induced diabetic rats [2]. Green tea also
prevents an increase in creatinine clearance [3]. Judging
from serum creatinine levels, GTE obliterates cisplatin-
induced nephrotoxicity in rats [4-6]. Moreover, GTE also
exerts antiproteinuric effects on cyclosporine-induced
nephrotoxicity in rats [7]. Furthermore, GTE reverses
the progression of immune-mediated glomerulonephritis
in mice [8]. GTE may exert these protective effects on
renal damage through its antioxidant activity [2,4-9].
However, Inoue et al. reported that a diet containing
high-dose green tea polyphenols disrupts renal function
in both mice with dextran sulfate sodium-induced colitis
and normal mice [20]. They assumed that high-dose
green tea polyphenols down-regulate antioxidant en-
zymes, leading to kidney dysfunction. However, in human
subjects, to our knowledge, there is no solid evidence
reporting beneficial effects of green tea consumption on
renal function. A clinical trial reported that green teasumption status and ND2-237 Leu/Met genotype
eGFR† (ml/min/1.73 m2) eGFR‡ (ml/min/1.73 m2)
80.1 ± 1.6 78.5 ± 2.0
79.6 ± 1.5 77.2 ± 2.0
77.1 ± 1.7 74.4 ± 2.1
79.2 ± 1.7 76.6 ± 2.2
P for trend = 0.484 P for trend = 0.262
84.1 ± 1.8 81.7 ± 2.4
79.6 ± 1.7 77.6 ± 2.3
82.5 ± 2.1 82.2 ± 2.6
80.4 ± 2.3 79.0 ± 2.8
P for trend = 0.355 P for trend = 0.674
. adjusted for age, body mass index; ‡eGFR is given as least-square mean ± S.E.
consumption and antihypertensive medication use. Bonferroni correction for
Table 3 Odds ratios (ORs) and 95% confidence intervals (CIs) for decreased eGFR (< 90 ml/min/1.73 m2) by ND2-237
Leu/Met genotype and green tea consumption status
Genotype and green tea consumption OR (95% CI) Adjusted OR† (95% CI) Adjusted OR‡ (95% CI)
ND2-237Leu
≤1 cup per day 1 (reference) 1 (reference) 1 (reference)
2–3 cups per day 1.957 (0.857–4.466) 1.777 (0.748–4.223) 2.240 (0.864–5.808)
4–5 cups per day 2.152 (0.849–5.453) 1.279 (0.457–3.578) 1.509 (0.502–4.533)
≥6 cups per day 4.598 (1.445–14.63)* 3.134 (0.938–10.47) 5.647 (1.528–20.88)**
P for trend = 0.007 P for trend = 0.064 P for trend = 0.016
ND2-237Met
≤1 cup per day 1 (reference) 1 (reference) 1 (reference)
2–3 cups per day 2.250 (0.886–5.715) 2.251 (0.886–5.718) 2.943 (1.023–8.461)*
4–5 cups per day 1.540 (0.555–4.271) 1.499 (0.525–4.280) 1.136 (0.344–3.749)
≥6 cups per day 2.054 (0.687–6.143) 1.597 (0.490–5.204) 0.984 (0.260–3.721)
P for trend = 0.256 P for trend = 0.500 P for trend = 0.903
eGFR: estimated glomerular filtration rate. †OR adjusted for age and body mass index. ‡OR adjusted for age, body mass index, habitual smoking, alcohol
consumption, coffee consumption and antihypertensive medication. *P < 0.05, **P < 0.01.
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young adults, while coffee consumption increases it
[21]. Population-based prospective studies, at least cross-
sectional studies, focusing on the association between
green tea consumption and renal function or risk of
chronic kidney disease (CKD) are thus necessary.
NADH dehydrogenase is recognized as the major
physiological and pathological site of reactive oxygen
species (ROS) generation in mitochondria, and as a
target of attack by ROS [22]. There may be biophy-
sical and biochemical differences in the protection
against ROS or the reduction of ROS generation
between ND2-237Leu and ND2-237Met. Considering
the results from experimental animal models [23,24],
ND2-237Met may suppress ROS production and/or
protect NADH dehydrogenase itself from ROS. There-
fore, in order to determine the mechanisms res-
ponsible for the unexpected joint effects of ND2-237
Leu/Met genotypes and green tea consumption on
renal function, further biophysical and biochemical in-
vestigations are necessary.
In addition to other molecular epidemiological studies
[25,26] and our previous study [19], in accordance with
Kidney Disease Outcomes Quality Initiative (K/DOQI)
CKD classification [27], eGFR of <90 ml/min/1.73 m2
was defined as reduced eGFR in this cross-sectional
study. In the present subjects, the prevalence of eGFR
of <90 ml/min/1.73 m2 was 82.4% in men with ND2-237
Leu and was 74.8% in those with ND2-237 Met. A
large-scale population-based epidemiological study
showed that the prevalence of eGFR of <90 ml/min/
1.73 m2 was above 80% in Japanese men aged 30–69
years [28]. Hence, the validity of the definition ofreduced eGFR adopted in this study is worth further
consideration.
This study has several critical limitations. First, the
study sample size was insufficient. Second, in addition to
information bias due to the self-reported questionnaire,
selection bias is probable due to the recruiting of sub-
jects from those visiting the hospital for regular medical
check-ups, and the prevalence of moderately decreased
eGFR of <60 ml/min/1.73 m2, generally recognized as
CKD, was low among study subjects. Third, this study
was a cross-sectional study, and although the study de-
sign is able to suggest causal links, it cannot determine
rational causality. To overcome these limitations, a
large-scale population-based prospective study is neces-
sary. Fourth, the evaluation of green tea consumption
was based on the number of cups consumed per day. Al-
though we have used this evaluation method previously
[18], we will require data on serving size, green tea
brands and purity, and concentrations of GTE, such as
(−)-epigallocatechin-3-gallate, and other catechins in
green tea, for further investigations. Fifth, data on diet-
ary factors or socioeconomic factors, which are reported
as risk factors for CKD [29], were not collected in this
study. Finally, we lacked data on proteinuria, which is an
early and sensitive marker of kidney damage in various
types of CKD [28]. Therefore, future research should
examine proteinuria in order to preventively estimate
renal damage.
Conclusion
Despite several crucial limitations in this study, longe-
vity-associated ND2-237 Leu/Met polymorphism ap-
pears to modulate the effects of green tea consumption
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Japanese men. Surprisingly, for ND2-237Leu genotypic
men, green tea intake may decrease eGFR or increase
the risk of mildly decreased eGFR. From the viewpoint
of preventing hypertension, green tea consumption is
recommended for men with ND2-237Leu [18]. There-
fore, considering that both hypertension and CKD are
risk factors of cardiovascular diseases, further investi-
gation will be necessary to establish the personalized
optimum for maximizing the risk reduction and minim-




Participants were recruited from among individuals visi-
ting the Mito Red Cross Hospital for regular medical
check-ups between August 1999 and August 2000. This
study was conducted in accordance with the Declaration
of Helsinki and was approved by the Ethics Committee
of the Kyorin University School of Medicine. Written
informed consent was obtained from 602 volunteers be-
fore participation. Because the number of women was in-
sufficient for classification into groups based on ND2-237
Leu/Met genotype and green tea consumption, women
were excluded. Due to glomerular hyperfiltration in early
diabetes [30], diabetic patients undergoing treatment were
also excluded. Thus, 406 men were enrolled in the study.
Twelve individuals with unclear data were also excluded.
Therefore, subjects comprised 394 Japanese men aged
29–76 years.
Clinical characteristics of subjects
Blood chemical and physical data in the present study
were obtained from the results of regular medical check-
ups [31]. Kidney function was evaluated by estimated
glomerular filtration rate (eGFR), which was calculated
using a three-variable Japanese equation: eGFR = 194 ×
creatinine-1.094 × age-0.287 [32]. Based on the K/DOQI
CKD classification [27], we adopted the criterion of an
eGFR of <90 ml/min/1.73 m2 for the mild reduction of
eGFR. Body mass index (BMI) was defined as the ratio
of subject weight (kg) to the square of subject height
(m). A survey of green tea consumption, alcohol con-
sumption, habitual smoking and coffee consumption
was performed by means of questionnaire. Green tea
consumption was classified based on number of cups of
green tea per day (≤1 cup per day; 2–3 cups per day;
4–5 cups per day; and ≥6 cups per day). Alcohol con-
sumption was classified based on drinking frequency
(daily drinkers; occasional drinkers, including those who
drink several times per week or per month; and non-
or ex-drinkers). Smoking status was classified based
on number of cigarettes smoked per day (non- or ex-smokers; 1–20 cigarettes smoked per day; and >20
cigarettes smoked per day). Coffee consumption was
classified based on number of cups of coffee per day
(≤1 cup per day; 2–3 cups per day; and ≥4 cups per
day). Subjects were also classified as taking or not
taking antihypertensive medication.
Genotyping
DNA was extracted from white blood cells using the
DNA Extractor WB kit (Wako Pure Chemical Industries,
Osaka, Japan). ND2-237 Leu/Met polymorphism was de-
tected by polymerase chain reaction (PCR) and digestion
with AluI restriction enzyme. The sequence of primers
was: forward 5’-CTTAGCATACTCCTCAATTACCC-3’;
and reverse 5’-GTGAATTCTTCGATAATGGCCCA-3’.
PCR was performed with 50 ng genomic DNA in buffer
containing 0.2 μmol/l of each primer, 1.25 mmol/l
dNTPs, 1.5 mmol/l MgCl2 and 1 U of Taq DNA poly-
merase. After an initial denaturation at 94°C for 5 min,
PCR was conducted through 40 cycles in the following
steps: denaturation at 94°C for 30 s, annealing at 60°C
for 60 s and polymerase extension at 72°C for 90 s. After
cycling, a final extension at 72°C for 10 min was per-
formed. PCR products were digested with AluI restric-
tion enzyme (Nippon Gene, Tokyo, Japan) at 37°C
overnight, and were electrophoresed in 1.5% agarose gels
stained with ethidium bromide for visualization under
ultraviolet light. The absence of an AluI site was desig-
nated as ND2-237Met, and the presence of this restric-
tion site was designated as ND2-237Leu.
Statistical analyses
Statistical analyses were performed using SAS statistical
software version 9.2 for Windows. Multiple logistic re-
gression analysis was used to calculate odds ratios (ORs)
for the reduction of eGFR (<90 ml/min/1.73 m2). For
multiple logistic regression analysis and analysis of co-
variance, alcohol consumption (non- or ex-drinkers = 0,
occasional drinkers, including those who drink several
times per week or per month = 1, daily drinkers = 2),
coffee consumption (≤1 cup per day = 1, 2–3 cups per
day = 2, ≥4 cups per day = 3), habitual smoking (non- or
ex-smokers = 0, 1–20 cigarettes smoked per day = 1, >20
cigarettes smoked per day = 2), and antihypertensive me-
dication use (no use of antihypertensive = 0, use of anti-
hypertensive = 1) were numerically coded. Differences
with P values of less than 0.05 were considered to be sta-
tistically significant.
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